MOLECULAR PARTNERS ADS/1 Financial Flexibility Index
MOLECULAR PARTNERS ADS/1 financial flexibility index. MOLECULAR PARTNERS ADS/1 (6ML0) has a Financial Flexibility Index of -0.63x as of June 2026. Free cash flow of €-10.79 Million (operating CF €-10.79 Million minus capex €0.00) represents -1% of total liabilities (€17.15 Million). See cash generation quality of MOLECULAR PARTNERS ADS/1 to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of MOLECULAR PARTNERS ADS/1 (2021–2025)
Financial flexibility index of MOLECULAR PARTNERS ADS/1 from 2021 to 2025. Historical Financial Flexibility Index trend for MOLECULAR PARTNERS ADS/1 across 5 annual periods. Check 6ML0 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
MOLECULAR PARTNERS ADS/1 Financial Flexibility Index by Year (2021–2025)
MOLECULAR PARTNERS ADS/1 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for MOLECULAR PARTNERS ADS/1. For the full cash flow conversion analysis, see cash efficiency ratio of MOLECULAR PARTNERS ADS/1.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.32x | €-50.54 Million | €-51.26 Million | €21.77 Million | ▲ +33.0% |
| 2024 | -3.46x | €-58.52 Million | €-59.25 Million | €16.89 Million | ▼ -30.5% |
| 2023 | -2.65x | €-58.20 Million | €-59.01 Million | €21.92 Million | ▼ -159.9% |
| 2022 | 4.43x | €119.98 Million | €118.57 Million | €27.09 Million | ▲ +423.0% |
| 2021 | -1.37x | €-89.65 Million | €-90.95 Million | €65.38 Million | — |